Peregrine Pharmaceuticals reported $26.11M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Agenus AGEN:US $ 252.95M 242.22M
Amgen AMGN:US $ 6706M 180M
AstraZeneca AZN:LN 9866M 1646M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Bristol Myers Squibb BMY:US $ 11624M 79M
Celldex Therapeutics CLDX:US $ 0.15M 3.33M
Chemocentryx CCXI:US $ 17.74M 15.93M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
GlaxoSmithKline GSK:LN 9077M 985M
Immunogen IMGN:US $ 9.21M 7.74M
Intrexon XON:US $ 21.56M 12.02M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Kindred Biosciences KIN:US $ 3.54M 1.14M
Macrogenics MGNX:US $ 15.66M 15.1M
Mannkind MNKD:US $ 22.21M 1.07M
Merk MRK:US $ 13154M 1752M
Minerva Neurosciences NERV:US $ 0 0
Newlink Genetics NLNK:US $ 0M 0.01M
Novartis NOVN:VX SF 13367M 73M
Novavax NVAX:US $ 178.84M 119.17M
Peregrine Pharmaceuticals PPHM:US $ 26.11M 4.64M
Repligen RGEN:US $ 178.22M 15.26M
Xencor XNCR:US $ 19.68M 47.76M